To analyze cohorts of IgGs and mAb based modalities using mass spectrometry characterization using a complete analytical workflow on a single workhorse instrument.
Require a single, complete MS platform that can handle a diversity of the analytical workflows- intact mass, peptide mapping in reduced and non-reduced conditions, and relative quantitation of post-translational modifications
Need an easy-to-use MS system that does not require extensive training. Walk-up resource, ready to use instantly
Want automated calculations and customized reporting for data that relies on minimal external intervention
The X500B QTOF System, a robust LC-MS platform with:
Good sensitivity & linear dynamic range
User-friendly data acquisition system
Dedicated BioPharmaView™ Software to do a full characterization of biotherapeutics
After a quick calibration, the X500B QTOF is ready to use within minutes
The system is easy-to-use. New users in the team can be trained within a few hours, and are completely operational
After six-months of operation, and around 2000 injections, no downtime has occurred, and there has been minimal cleaning of the source
The BioPharmaView software solution allows for step-by-step biotherapeutic characterization, for naked antibodies and even immunoconjugates
“The accuracy and sensitivity of the X500B LC-MS instrument, with improved robustness, allows for monitoring of manufacturing batches with increased analytical throughput.”
Type of Organization
Sanofi S.A. is a global healthcare leader in biopharmaceuticals. The structural analysis department specializes in mass spectrometry and structural analysis for biologics characterization.
To gain better knowledge of biopharmaceutical products in development by reliable mass spectrometry characterization at the intact protein and peptide level.
Data Independent Acquisition (DIA)
Intact Protein Analysis
Post-Translational Modification Analysis
X500B QTOF System
SCIEX OS Acquisition Software
“The follow-up of post-translational modifications with non-targeted and targeted (MAM) workflows is becoming mandatory to develop a new project.”
Answers for Science. Knowledge for Life.™
RUO-MKT-07-7620-A For Research Use Only. Not for use in diagnostic procedures.